Sobre la Empresa
- Nombre legal: Shanghai Famo Biotechnology Co.,Ltd.
- Nombre internacional: 上海法默生物科技有限公司 (Shanghai Famo Biotechnology Co., Ltd.), Shanghai, China
- Marca / Nombre comercial: Famo Biotechnology
- País de registro: China
- Dirección: ShanghaiShanghaiBuilding 2, No. 3399, Kangxin Road, Pudong New Area, Shanghai • Shanghai
Descripción:
Founded in 2011 and headquartered in Pudong New Area, Shanghai, Shanghai Famo Biotechnology Co.,Ltd. (famobiotech.com) is a manufacturer of active pharmaceutical ingredients and pharmaceutical intermediates, with an extensive catalog geared toward advanced small-molecule drug synthesis. Its product range includes intermediates and APIs for modern therapeutics such as gedatolisib, elafibranor, acoramidis, capivasertib, fruquintinib, darolutamide, asciminib, ivacaftor, difamilast, elacestrant, momelotinib, aprocitentan, finerenone, daprodustat, afatinib, prucalopride, apalutamide, enzalutamide, roxadustat, gilteritinib, bempedoic acid and tucatinib, alongside numerous specialty building blocks used in their synthesis. The company offers CMO and CDMO contract services, and highlights brand strength, experienced R&D personnel, delivery speed, production capacity, a rich product line, and willingness to accommodate small orders and buyer specifications, selling across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa.
Actividades Comerciales
Productos químicos, solventes y estándares de referencia de laboratorio
Proveedor
Químicos Farmacéuticos
DistribuidorProveedor de Síntesis a MedidaFabricante
Ingredientes Farmacéuticos Activos (API)
Fabricante
Mercados de Venta
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Productos/Servicios Clave
- Químicos Farmacéuticos: 4-[(3R)-3-[[(4-cyano-1H-indol-6-yl)carbonyl]amino]-2-oxopyrrolidin-1-yl]-2-hydroxybenzoic acid, Bedaquiline (Mixture of DiastereoMers), (4-Aminophenyl)(4-(dimethylamino)piperidin-1-yl)methanone, 4-(4,6-dimorpholino-1,3,5-triazin-2-yl)aniline, 1-(3-cyano-4-((dimethylamino)methyleneamin, 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino )cyclobutanecarboxylic acid, 1-(3-Methoxypropyl)-4-piperidinamine, 1-(1-(3-Methoxy-4-nitrophenyl) piperidin-4-yl)-4-methylpiperazine, 1-(1-Methyl-4-piperidinyl)piperazine, 1-(2-hydroxyethyl)-4-methyl-5-(2-(trifluoromethyl)phenyl)-1H-pyrrole-3-carboxylic acid, 1-Aminocyclobutanecarboxylic acid, 1-AMINOCYCLOBUTANECARBOXYLIC ACID HYDROCHLORIDE, 1-Methyl -4-(4-piperidinyl) piperazine, 1-methyl-4-(piperidin-4-yl)piperazine 3hcl, 1-(Tetrahydropyran-2-yl)-1H-pyrazole-5-boronic acid pinacol ester, 1,1-DimethylethylN-ethyl-N-[2-(4-formylphenyl)ethyl]carbamate, 1,1'-THIOCARBONYLDI-2(1H)-PYRIDONE, 1,1'-Thiocarbonyldiimidazole, [1,2,4]Triazolo[1,5-a]pyridin-7-ol, [1,2,4]Triazolo[1,5-a]pyridine, 7-(2-methyl-4-nitrophenoxy)-, [(1,3-Dicyclohexyl-2,4,6-trioxo-hexahydro-pyrimidine-5-carbonyl)-amino]-acetic acid ethyl ester, 2-Bromo-N-ethyl-5-methoxybenzenamine, 1H-Pyrrole-3-carboxylic acid, 1-(2-hydroxyethyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-, ethyl ester, 1H-Pyrrole-3-carboxylic acid, 4-methyl-5-[2-(trifluoromethyl)phenyl]-,ethyl ester, [2-(4-(broMoMethyl)phenyl)ethyl]carbaMic acid tert-butyl ester, 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid, 2-((5-bromopyrimidin-2-yl)oxy)ethan-1-ol, 2-Amino-2-(pyridin-3-yl)acetonitrile, 2-Amino-4-chloropyridine, 2-Amino-4-methoxypyridine, 2-amino-acetonitrile hydrochloride, 2-Aminopyridin-4-ol, 2-Bromo-1-(2 trifluoromethylphenyl)-propan-1-one, 2-bromo-3,4-dihydro-6-hydroxynaphthalen-1(2H)-one, 2-bromo-5-methoxyaniline, 2-BROMO-5-METHOXYANILINE HCL, 2-Bromo-5-nitro-3-(trifluoromethyl)pyridine, 2-Chloro-4-(1H-Pyrazol-5-Yl)Benzonitrile, 2-Chloro-4-(1h-pyrazol-5-yl)benzonitrile hydrochloride, 2-Chloro-N-methylacetamide, 2-Cyano-N-(2,4-Dichloro-5-Methoxyphenyl) Acetamide, 2-Cyanoethyl 3-oxobutanoate, 2-(Dimethyloxyphosyl) aniline, 2-Hydroxy-5-nitro-3-(trifluoromethyl)pyridine, 2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline, 2-Naphthalenol, 6-(2-amino-4-methoxyphenyl)-5,6,7,8-tetrahydro-, (6R)-, 2-Phenylacetophenone, 2-Phenylacetophenone oxime, 2-Propen-1-one, 3-(4-hydroxy-3,5-dimethylphenyl)-1-[4-(methylthio)phenyl]-, 2-Pyrazinecarbonitrile, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-, 2'-(Trifluoromethyl)propiophenone, 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid, 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid diethyl ester, 4-isothiocyanato-2-(trifluoromethyl)benzonitrile, 2,4-Dichloro-5-methoxyaniline, 2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dicyclohexyl, 2,5-dichloro-N-(2-(dimethylphosphoryl)phenyl)pyrimidin-4-amine, 2,6-Dichloro-3,5-dimethoxyaniline, 3-(1-(3-(5-bromopyrimidin-2-yl)benzyl)-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, 3-(1-(3-(5-hydroxypyrimidin-2-yl)benzyl)-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile, 3-(2,6-Dichloro-3,5-Dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl) phenyl] amino] pyrimidin-4-yl]-1-methylurea, 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1-methylpyridinium iodide, 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]-Benzoic acid Methyl ester, 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid, (3-(5-broMopyriMidin-2-yl)phenyl)Methanol, 3-(5-HydroxypyriMidin-2-yl)benzoic acid Methyl ester, 3-(6-Oxo-1,6-dihydro-3-pyridazinyl)benzonitrile, 3-acetylbenzonitrile, 3-bromo-5-chloro-6-ethylpyrazine-2-carbonitrile, 3-bromo-6-ethyl-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carbonitrile, 3-Chloro-4-(pyridin-3-yl)-1,2,5-thiadiazole, 3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid, 3-(hexyloxy)-4-(pyridin-3-yl)-1,2,5-thiadiazole, 3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline, 3-Pyridineacetonitrile, α-hydroxy-, 3-Pyridinecarboxamide, 5-bromo-6-chloro-N-[4-(chlorodifluoromethoxy)phenyl], 3-Pyridinecarboxamide, 5-bromo-N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxy-1-pyrrolidinyl]-, 3,5-Dimethoxybenzaldehyde, 3,5-dimethoxybenzyl alcohol, 4-[(1-cyanocyclobutyl)amino]-N-methylbenzamide, 4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline, 4-(2-(4-MorpholinophenylaMino)pyriMidin-4-yl)benzoic acid, 4-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]benzoic acid methyl ester, 4-(3-Bromopropyl)-3,5-dimethyl-1H-pyrazole, 4-(4-Ethylpiperazin-1-ly)aniline, 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonyl chloride, 4-Acetylamino-5-Chloro-2-Hydroxybenzoic Acid Methyl Ester, 4-Amino-2-hydroxy-5- methylpyridine, 4-Amino-5-chloro-2,3-dihydro-7-benzofurancarboxylic acid, 4-Bromo-2-fluoro-N-methylbenzamide, 4-Bromo-3-nitroanisole, 4-Chloro-4'-fluorobutyrophenone, 4-(chloro-difluoro-methoxy)-phenylamine, 4-(difluoromethoxy)-3-(cyclopropylmethoxy)-benzaldehyde, 4-DifluoroMethoxy-3-hydroxybenzaldehyde, 4-formyl-3-methoxybenzonitrile, 4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester, 4-hydroxy-1-methyl-7-phenoxy-3-Isoquinolinecarboxylic acid, 4-hydroxy-1-methyl-7-phenoxy-3-Isoquinolinecarboxylic acid ethyl ester, 4-(Hydroxymethyl)Phenylacetic Acid, 4-hydroxyquinoline-3-carboxylic acid, 4-Morpholinoaniline, 4-(Piperidin-4-yl)morpholine, 4-(Piperidin-4-yl)Morpholine hydrochloride, 4-QuinazolinaMine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-, 4,6-Quinazolinediamine, N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-, (4aS,9bR)-6-bromo-1H,2H,3H,4H,4aH,5H,9bH-pyrido[4,3-b]indole, (4aS,9bR)-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole, 5-(4-Bromophenyl)-4,6-dichloropyrimidine, 5-Acetyl-1H-Pyrazole-3-carboxylic acid, 5-AMino-2,4-di-tert-butylphenol, 5-AMINO-3-(TRIFLUOROMETHYL)PICOLINONITRILE, 5-broMo-2-(3-(chloroMethyl)phenyl)pyriMidine, 5-Bromo-2-chloropyrimidine, 5-Bromo-6-chloronicotinic acid, (5-Isothiocyanato-3-(trifluoromethyl)picolinonitrile), 5-Isoxazolol, 4,5-dihydro-5-methyl-3,4-diphenyl-, 5-Methyl-3,4-diphenyl- Isoxazole, 5-Nitro-3-trifluoroMethylpyridine-2-carbonitrile, 5-Phenoxyisobenzofuran-1(3H)-one, 6-Cyano-2-[1-[4-Ethyl-3-[4-(4-morpholinyl)-1-piperidinyl] phenyl]-1-methylethyl]-1H-indole-3-carboxylic acid tert-butyl ester（base）, 6-Hydroxy-1-tetralone, 6-Hydroxy-N,2-dimethylbenzofuran-3-carboxamide, 6-Methoxy-1-Tetralone, 6-nitroquinazolin-4(3h)-one, 6-(tert-Butoxycarbonyl)-3,6-diazabicyclo [3.1.1] heptane, (6bR,10aS)-2,3,6b,7,8,9,10,10a-Octahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline dihydrochloride, (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline hydrochloride, (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, (6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate, (6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylat, 7-(Benzyloxy)-3-bromo-1,2-dihydronaphthalene, 9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile, Acetamide, N-[2-[3,4-dihydro-6-(phenylmethoxy)-2-naphthalenyl]-5-methoxyphenyl]-, Acetic acid, 2-[[4-(methylsulfonyl)phenyl]amino]-2-oxo-, 2-[(2S)-3-methyl-4-[[[4-(methylsulfonyl)phenyl]amino]carbonyl]-2-[2-(trifluoromethyl)phenyl]-1H-pyrrol-1-yl]ethyl ester, Acoramidis, Afatinib, Afatinib DiMaleate, Alectinib Hydrochloride, Alectinib（base）, AP26113/brigatinib, Apalutamide, Aprocitentan, Asciminib base, Asciminib HCL, BEMPEDOIC ACID, Benzaldehyde, 4-(difluoromethoxy)-3-(1-methylethoxy)-, Benzamide, 4-(difluoromethoxy)-3-(1-methylethoxy)-, Benzamide, N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-, hydrochloride, hydrate (1:2:1), Benzeneacetamide, N-ethyl-4-formyl-, Benzoic acid, 4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-, methyl ester, Benzoic acid, 4-(difluoromethoxy)-3-(1-methylethoxy)-, Capivasertib, Daprodustat, Darolutamide, diethylphosphonoacetic acid, Difamilast, Dimethyl Phosphine Oxide, (E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide, Elacestrant, Elacestrant dihydrochloride, Elafibranor, Enzalutamide, ESAX-010, Esaxerenone, ethyl-2,2-dimethyl-7-bromoheptanoate, ethyl 4-(2-chloropyriMidin-4-yl)benzoate, ethyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate, Ethyl Isocyanatoacetate, ethyl(4aS,9bR)-6-bromo-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3-b]indole-2-carboxylate, Finerenone, Methanesulfonic acid, 1,1,1-trifluoro-, compd. with 4,5-dihydro-4,4-dimethyl-2-(methylthio)oxazole (1:1), Fruquintinib, Gedatolisib, Gilteritinib, Gilteritinib hemifumarate, Methyl 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino) cyclobutanecarboxylate, methyl 1-bromo-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate1-, Methyl-2-(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxamido)acetate, Methyl 2-(4-methylphenylsulfonamido)acetate, Methyl 3,5-dimethoxybenzoate, Heptanoic acid, 7-chloro-2,2-dimethyl-, ethyl ester, Methyl 4-(acetylaMino)-3-broMo-2-(2-broMoethoxy)-5-chlorobenzoate, Methyl 4-(acetylaMino)-3-broMo-5-chloro-2-hydroxybenzoate, Methyl 4-(acetylaMino)-5-chloro-2,3-dihydro-1-benzofuran-7-carboxylate, Methyl 4-acetylbenzoate, methyl 4-fluoro-3-hydroxybenzoate, Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate, Methyl 5-bromo-6-chloropyridine-3-carboxylate, IVACAFTOR, Pharmaceutical Intermediates, Research chemicals, lasofoxifene （tartrate）, Lasofoxifene(base), Lumateperone(base), Lumateperone(tosilate), methyl(R)-5-bromo-6-(3-hydroxypyrrolidin-1-yl)nicotinate, Momelotinib, Momelotinib Dihydrochloride, N-乙酰基-2-溴-5-甲氧基苯胺, N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine, N-[3-fluoro-4 -[(methylamino) carbonyl] phenyl] -2-methylalanine methyl ester, N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-diethoxyphosphorylacetamide, N'-(4-Amino-2-cyanophenyl)-N,N-dimethylformamidine, N-[4-(Morpholin-4-yl)phenyl]guanidine, N-[4-(morpholin-4-yl)phenyl]guanidine hydrochloride, N-[5-(4-broMophenyl)-6-chloro-4-pyriMidinyl]-N'-(phenylMethyl)-, N-Boc-1-aminocyclobutanecarboxylic acid, N-BOC-4-piperidinemethanol, N-BOC-Amino-piperidinyl -1,1-carboxylic acid, N-Methyl-4-anisidine, N4-(4-(4-ethylpiperazin-1-yl)phenyl)-N6- MethylpyriMidine-4,6-diaMine, Nafoxidine, Nafoxidine（hydrochloride）, Parecoxib, Parecoxib Sodium, Propanoic acid, 2-[2,6-dimethyl-4-[3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methyl-, 1,1-dimethylethyl ester, PropylsulfaMide, PRUCALOPRIDE, Prucalopride succinate*, Pyrimidine, 5-(4-bromophenyl)-4-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-6-chloro-, R-(+)-3-Hydroxypyrrolidine, ROFLUMILAST, Roxadustat, (S)-3-(4-chlorophenyl)-beta-alaninol, (S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile, Tucatinib, Tucatinib N-1, Tepotinib Hydrochloride, Tepotinib（base）, Tert-butyl 6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylate hydrochloride, tert-butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate, VALDECOXIB, Xanomeline, Xanomeline tartrate
- Productos químicos, solventes y estándares de referencia de laboratorio: Impurity Standard Set
- Servicios de contratación y externalización: Custom Synthesis
Nuestros Productos & Servicios
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · Pharma Chemicals
Certifications
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario